Companies

Companies

featured image of Huge €410M Licensing Deal for Fibro-Inflammatory Disease Treatments

Huge €410M Licensing Deal for Fibro-Inflammatory Disease Treatments

BIOT

📣 Boehringer Ingelheim partners with Kyowa Kirin Co., Ltd. for €410m license deal to treat fibro-inflammatory diseases! 🧪💰

featured image of miRNA Specialist Resalis Therapeutics Raises €10m for Groundbreaking Obesity Treatment

miRNA Specialist Resalis Therapeutics Raises €10m for Groundbreaking Obesity Treatment

BIOT

💰 Italian biotech Resalis Therapeutics raises €10m in Series A funding for obesity treatment RES-010. 🍔💪📈

featured image of Goldman Sachs Raises $650 Million for Life Sciences Investments: A Game-Changer for Medical Innovations

Goldman Sachs Raises $650 Million for Life Sciences Investments: A Game-Changer for Medical Innovations

BIOT

🏦 Goldman Sachs raises $650m for life sciences investments, showing growing interest in the sector. 💼🔬💰

featured image of Oligo Factory Achieves GMP Compliance: Exceptional Quality Control and Regulatory Standards

Oligo Factory Achieves GMP Compliance: Exceptional Quality Control and Regulatory Standards

BIOT

📢 Oligo Factory achieves GMP compliance! 🏭 CEO Chris Boggess celebrates the team's hard work in maintaining high-quality standards. 💼💯

featured image of Big Moves in Biotech: Veranova Beam and AAX

Big Moves in Biotech: Veranova Beam and AAX

BIOT

📰 Exciting changes ahead in the global biotech industry! Veranova, Beam, and AAX Biotech announce top-level team shuffles. Stay tuned! 🌍💼🔬

featured image of Revolutionary Cell Transport Tech: No Cryopreservation Needed!

Revolutionary Cell Transport Tech: No Cryopreservation Needed!

BIOT

📰 Likarda, a company spun out of the University of Kansas, revolutionizes cell transportation with Core-Shell Spherification, eliminating cryopreservation. 👩‍🔬🔬👨‍🔬

featured image of BMS Expands Oncology Portfolio with $41bn RayzeBio Acquisition

BMS Expands Oncology Portfolio with $41bn RayzeBio Acquisition

BIOT

💼 Bristol Myers Squibb (BMS) acquires RayzeBio for $4.1bn, expanding its oncology portfolio with targeted radiopharmaceuticals. ⚕️🎯

featured image of Meet Christopher Riley: The New CEO Revolutionizing Biotechnology

Meet Christopher Riley: The New CEO Revolutionizing Biotechnology

BIOT

🌍 Christopher Riley takes the reins as CEO of Cytiva, a global biotechnology company, driving innovation and growth. 🌟💼🔝

featured image of AstraZeneca's Big Cell Therapy Breakthrough: Gracell Acquisition

AstraZeneca’s Big Cell Therapy Breakthrough: Gracell Acquisition

BIOT

📢 AstraZeneca accelerates cell therapy ambitions through Gracell buy 🌱 Expanding capabilities, boosting oncology portfolio, and driving scientific innovation. 💪🏢🌍

featured image of Novo Nordisk's Bold Move to Boost Diabetes Treatment Production in Ireland!

Novo Nordisk’s Bold Move to Boost Diabetes Treatment Production in Ireland!

BIOT

Novo Nordisk📢 seeks permission in Ireland to expand GLP-1 production🏭, boosting diabetes treatment📈 & job opportunities💼. pharmaceuticals